Off-Label Drug Use in a Single-Center Pediatric Cardiac Intensive Care Unit

World Journal for Pediatric and Congenital Heart Surgery

Volumn 4, Issue 3, 2013, Pages 262-266

  Maltz, Lily A ^a   Klugman, Darren ^a   Spaeder, Michael C ^a   Wessel, David L ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

congenital heart disease; critical care; off label drugs; pediatrics

Indexed keywords

CONGENITAL HEART DISEASE; CRITICAL CARE; OFF-LABEL DRUGS; PEDIATRICS;

CHILD; CHILD, PRESCHOOL; CORONARY CARE UNITS; EPIDEMIOLOGIC METHODS; FEMALE; HEART DISEASES; HUMANS; INFANT; INTENSIVE CARE; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; OFF-LABEL USE; RESPIRATION, ARTIFICIAL;

CEFAZOLIN; CHLOROTHIAZIDE; DOPAMINE; ENALAPRIL; FENTANYL; FUROSEMIDE; HEPARIN; HORMONE; MIDAZOLAM; MILRINONE; MORPHINE; ONDANSETRON; OXYCODONE; PARACETAMOL; RANITIDINE; SPIRONOLACTONE; STEROID; VECURONIUM;

ARTICLE; ARTIFICIAL VENTILATION; CHILD; COHORT ANALYSIS; CORONARY CARE UNIT; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; OFF LABEL DRUG USE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84913611482     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135113481042     Document Type: Article

References (25)

1. Marelli AJ Mackie AS Ionescu-Ittu R Rahme E Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007; 115(2):163–172.
2. Gilboa SM Salemi JL Nembhard WN Fixler DE Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation. 2010; 122(22):2254–2263.
3. Khairy P Ionescu-Ittu R Mackie AS Abrahamowicz M Pilote L Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010; 56(14):1149–1157.
4. Shah SS Hall M Goodman DM, et al Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007; 161(3):282–290.
5. O’Donnell CP Stone RJ Morley CJ. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics. 2002; 110(5):e52.
6. Popernack ML Thomas NJ Lucking SE. Decreasing unplanned extubations: utilization of the Penn state children’s hospital sedation algorithm. Pediatr Crit Care Med. 2004; 5(1):58–62.
7. De Oliveira NC Ashburn DA Khalid F, et al. Prevention of early sudden circulatory collapse after the Norwood operation. Circulation. 2004; 110(11 suppl 1):II133–II138.
8. Dellinger RP Levy MM Carlet JM, et al Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36(1):296–327.
9. Pasquali SK Hall M Slonim AD, et al Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease. Circ Cardiovasc Qual Outcomes. 2008; 1(2):74–83.
10. Turner S Longworth A Nunn AJ Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998; 316(7128):343–345.
11. Conroy S Choonara I Impicciatore P, et al Survey of unlicensed and off label drug use in paediatric wards in European countries. European network for drug investigation in children. BMJ. 2000; 320(7227):79–82.
12. Conroy S McIntyre J Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999; 80(2):F142–F144.
13. Conroy S McIntyre J. The use of unlicensed and off-label medicines in the neonate. Semin Fetal Neonatal Med. 2005; 10(2):115–122.
14. Conroy S Newman C Gudka S. Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children. Ann Oncol. 2003; 14(1):42–47.
15. Bajcetic M Jelisavcic M Mitrovic J, et al Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol. 2005; 61(10):775–779.
16. Bazzano AT Mangione-Smith R Schonlau M Suttorp MJ Brook RH. Off-label prescribing to children in the United States outpatient setting. Acad Pediatr. 2009; 9(2):81–88.
17. Hsu B Brazelton T. Off-label medication use in an academic hospital pediatric critical care unit. WMJ. 2009; 108(7):343–348.
18. Curzon CL Milford-Beland S Li JS, et al Cardiac surgery in infants with low birth weight is associated with increased mortality: analysis of the society of thoracic surgeons congenital heart database. J Thorac Cardiovasc Surg. 2008; 135(3):546–551.
19. Allegaert K Verbesselt R Naulaers G, et al Developmental pharmacology: neonates are not just small adults. Acta Clin Belg. 2008; 63(1):16–24.
20. Hoffman TM Wernovsky G Atz AM, et al Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003; 107(7):996–1002.
21. Zuppa AF Nicolson SC Adamson PC, et al Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesth Analg. 2006; 102(4):1062–1069.
22. Hickey PR Hansen DD. Fentanyl- and sufentanil-oxygen-pancuronium anesthesia for cardiac surgery in infants. Anesth Analg. 1984; 63(2):117–124.
23. Hsu DT Zak V Mahony L, et al Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010; 122(4):333–340.
24. Schaefer F Litwin M Zachwieja J, et al Efficacy and safety of valsartan compared to enalapril in hypertensive children: a 12-week, randomized, double-blind, parallel-group study. J Hypertens. 2011; 29(12):2484–2490.
25. Burmester M Mok Q. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit. Intensive Care Med. 2005; 31(5):686–692.